| Dr Katie Shiver Googe, DO | |
|
309 Saint Lukes Dr, Montgomery, AL 36117-7109 | |
| (334) 356-3608 | |
| (334) 356-3621 |
| Full Name | Dr Katie Shiver Googe |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 4 Years |
| Location | 309 Saint Lukes Dr, Montgomery, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093327199 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | DO.2739 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wetumpka Urgent Care Llc | 6800053133 | 15 |
News Archive
Phase II study results of the agent ASA404 showed promise in patients with either squamous or non-squamous non-small cell lung cancer (NSCLC).
A receptor that is present in the nucleus of cells can, when activated, slow the growth of tamoxifen-resistant breast cancer cells, a new study found. The study built on the recent discovery that farnesoid X receptor — a nuclear receptor found mainly in the liver — is found in breast cancer tissue.
Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart tissues and deliver the electrical signals needed to keep those hearts beating.
The field of cell therapy, which aims to form new cells in the body in order to cure disease, has taken another important step in the development towards new treatments.
› Verified 4 days ago
| Entity Name | Ivy Creek Of Tallapoosa Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932130002 PECOS PAC ID: 8123938719 Enrollment ID: O20031229000288 |
News Archive
Phase II study results of the agent ASA404 showed promise in patients with either squamous or non-squamous non-small cell lung cancer (NSCLC).
A receptor that is present in the nucleus of cells can, when activated, slow the growth of tamoxifen-resistant breast cancer cells, a new study found. The study built on the recent discovery that farnesoid X receptor — a nuclear receptor found mainly in the liver — is found in breast cancer tissue.
Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart tissues and deliver the electrical signals needed to keep those hearts beating.
The field of cell therapy, which aims to form new cells in the body in order to cure disease, has taken another important step in the development towards new treatments.
› Verified 4 days ago
| Entity Name | Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598788218 PECOS PAC ID: 1557324811 Enrollment ID: O20041201000952 |
News Archive
Phase II study results of the agent ASA404 showed promise in patients with either squamous or non-squamous non-small cell lung cancer (NSCLC).
A receptor that is present in the nucleus of cells can, when activated, slow the growth of tamoxifen-resistant breast cancer cells, a new study found. The study built on the recent discovery that farnesoid X receptor — a nuclear receptor found mainly in the liver — is found in breast cancer tissue.
Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart tissues and deliver the electrical signals needed to keep those hearts beating.
The field of cell therapy, which aims to form new cells in the body in order to cure disease, has taken another important step in the development towards new treatments.
› Verified 4 days ago
| Entity Name | Physical Express |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043362734 PECOS PAC ID: 3476531039 Enrollment ID: O20050720000998 |
News Archive
Phase II study results of the agent ASA404 showed promise in patients with either squamous or non-squamous non-small cell lung cancer (NSCLC).
A receptor that is present in the nucleus of cells can, when activated, slow the growth of tamoxifen-resistant breast cancer cells, a new study found. The study built on the recent discovery that farnesoid X receptor — a nuclear receptor found mainly in the liver — is found in breast cancer tissue.
Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart tissues and deliver the electrical signals needed to keep those hearts beating.
The field of cell therapy, which aims to form new cells in the body in order to cure disease, has taken another important step in the development towards new treatments.
› Verified 4 days ago
| Entity Name | Ivy Creek Of Elmore Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558868323 PECOS PAC ID: 8426075508 Enrollment ID: O20051027001031 |
News Archive
Phase II study results of the agent ASA404 showed promise in patients with either squamous or non-squamous non-small cell lung cancer (NSCLC).
A receptor that is present in the nucleus of cells can, when activated, slow the growth of tamoxifen-resistant breast cancer cells, a new study found. The study built on the recent discovery that farnesoid X receptor — a nuclear receptor found mainly in the liver — is found in breast cancer tissue.
Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart tissues and deliver the electrical signals needed to keep those hearts beating.
The field of cell therapy, which aims to form new cells in the body in order to cure disease, has taken another important step in the development towards new treatments.
› Verified 4 days ago
| Entity Name | Wetumpka Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194057554 PECOS PAC ID: 6800053133 Enrollment ID: O20120130000098 |
News Archive
Phase II study results of the agent ASA404 showed promise in patients with either squamous or non-squamous non-small cell lung cancer (NSCLC).
A receptor that is present in the nucleus of cells can, when activated, slow the growth of tamoxifen-resistant breast cancer cells, a new study found. The study built on the recent discovery that farnesoid X receptor — a nuclear receptor found mainly in the liver — is found in breast cancer tissue.
Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart tissues and deliver the electrical signals needed to keep those hearts beating.
The field of cell therapy, which aims to form new cells in the body in order to cure disease, has taken another important step in the development towards new treatments.
› Verified 4 days ago
| Entity Name | Chilton Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366857674 PECOS PAC ID: 7517189855 Enrollment ID: O20141120002311 |
News Archive
Phase II study results of the agent ASA404 showed promise in patients with either squamous or non-squamous non-small cell lung cancer (NSCLC).
A receptor that is present in the nucleus of cells can, when activated, slow the growth of tamoxifen-resistant breast cancer cells, a new study found. The study built on the recent discovery that farnesoid X receptor — a nuclear receptor found mainly in the liver — is found in breast cancer tissue.
Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart tissues and deliver the electrical signals needed to keep those hearts beating.
The field of cell therapy, which aims to form new cells in the body in order to cure disease, has taken another important step in the development towards new treatments.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katie Shiver Googe, DO 309 Saint Lukes Dr, Montgomery, AL 36117-7109 Ph: (334) 356-3608 | Dr Katie Shiver Googe, DO 309 Saint Lukes Dr, Montgomery, AL 36117-7109 Ph: (334) 356-3608 |
News Archive
Phase II study results of the agent ASA404 showed promise in patients with either squamous or non-squamous non-small cell lung cancer (NSCLC).
A receptor that is present in the nucleus of cells can, when activated, slow the growth of tamoxifen-resistant breast cancer cells, a new study found. The study built on the recent discovery that farnesoid X receptor — a nuclear receptor found mainly in the liver — is found in breast cancer tissue.
Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart tissues and deliver the electrical signals needed to keep those hearts beating.
The field of cell therapy, which aims to form new cells in the body in order to cure disease, has taken another important step in the development towards new treatments.
› Verified 4 days ago
Miquel Angel Santiago, General Practice Medicare: Accepting Medicare Assignments Practice Location: 1845 Cherry St, Montgomery, AL 36107 Phone: 334-263-2301 Fax: 334-263-0886 | |
Oludayo Bamidupe Dawodu, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 4212 Carmichael Ct N, Montgomery, AL 36106 Phone: 334-213-8803 Fax: 334-213-8815 | |
Mrs. Audra Gabrielson Kerns, PA-C General Practice Medicare: Medicare Enrolled Practice Location: 1855 Halcyon Blvd, Montgomery, AL 36117 Phone: 334-530-6387 | |
Kiana K Foster, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 4371 Narrow Lane Rd, Suite 100, Montgomery, AL 36116 Phone: 334-613-3680 Fax: 334-613-3685 | |
Michael L Reeves, MD General Practice Medicare: Medicare Enrolled Practice Location: 520 S Hull St, Montgomery, AL 36104 Phone: 334-213-8803 Fax: 334-213-8815 | |
Ashley Darnell Mcintyre, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 129 Mitylene Park Ln, Montgomery, AL 36117 Phone: 334-279-8180 Fax: 334-279-8214 |